Case Study (Comorbidities)

Caring for senior patients with chronic diseases can be rather complex, especially in cases with numerous comorbidities. An example of such a case is Mary, an 81-year-old woman who has vascular dementia, type 2 diabetes mellitus, hypertension, hyperlipidemia, and osteoporosis. Proper control of her hypercholesterolemia is crucial to reducing cardiovascular risk and broadly considers her current cognitive state, as well as the growing need for care mentioned by Sara. This paper’s objectives are to optimize Mary’s hypercholesterolaemia medication schedule, ensure its compliance with national guidelines, determine the factors that impacted this patient’s quality of life because of vascular dementia, and recommend resources for Mary and Sara.

Case Overview

Mary is an 81-year-old Asian female with a significant past medical history of vascular dementia, type 2 diabetes mellitus, hypertension, hyperlipidemia, and osteoporosis. In the last few months, the client has been showing signs of declining cognitive ability, as evidenced by her memory loss and poor appetite. Sara, Mary's daughter, and her primary carer, reports that Mary needs more help in the management of the tasks of daily living and has been losing her medications several a week. Mary was diagnosed with a fractured hip two months ago after a fall at her home. Although this patient was recently hospitalized, she does not complain of pain or discomfort. These parameters include a weight of 115 pounds, height of 5'4", blood pressure 139/84 mm Hg, and hemoglobin A1c 6. 8% Her blood lipid levels are total cholesterol 210 mg/dL, LDL 118 mg/dL, HDL 60 mg/dL, and triglycerides 128 mg/dL. Mary takes aspirin, donepezil, sitagliptin, amlodipine, atorvastatin (50% to 75% intensity), ezetimibe, calcium, vitamin D, and acetaminophen as required. In light of her recent memory loss and missed medications, her hypercholesterolemia management, as well as a general medical plan, requires a reassessment to optimize her care.

Adjusting Mary’s Medication Regimen for Hypercholesterolemia

Proper management of hypercholesterolemia in elderly patients, including Mary, is essential to reduce cardiovascular risks and optimize the treatment of comorbidities. Thus, it is crucial to proceed with the modification of hypercholesterolemia in Mary, taking into consideration her age, previous diagnosis of vascular dementia, and current medication regimen. Hill & Bordoni (2023) suggest that the treatment plan for hyperlipidemia should consider the cardiovascular risk evaluation, mainly to prevent specific issues. Therefore,a moderate-intensity statin should be selected, and ezetimibe should be added to the patient’s therapy because of hypercholesterolemia.

Medication Adjustment Plan

Atorvastatin 20 mg daily

Atorvastatin belongs to the middle-potency statin class and can help lower LDL cholesterol and cardiovascular risk. As for elderly patients, atorvastatin is safe and greatly reduces LDL cholesterol without causing frequent side effects. There has been a concern that atorvastatin should be made the first-line treatment for hypercholesterolemia in elderly patients. This recommendation is made based on feasibility and risk analysis because this drug is safe for older people with comorbidities. Hill & Bordoni (2023) note that atorvastatin effectively lowers LDL levels and the risk of cardiovascular events in hypercholesterolemic individuals. Therefore, the decision to add 20 mg of atorvastatin daily to Mary’s therapy will improve her lipid profile and decrease her cardiovascular risk.

Ezetimibe 10 mg daily

The combination with ezetimibe lowers the LDL cholesterol level more effectively because it reduces its absorption in the intestine. This combination therapy is helpful in patients who may not reach their LDL goals with a single therapy using statin products. Ezetimibe adds value to statin treatment in those patients who require further lowering of LDL cholesterol. Concomitant use of ezetimibe with statin can have an additive effect of further cholesterol reduction. Hill & Bordoni (2023) stress that combining ezetimibe and statins can further increase cholesterol levels and patient outcomes. Hence, incorporating 10 mg of ezetimibe daily in Mary’s treatment regimen will be beneficial in managing her lipid profile.

Monitoring

Follow-up lipid profile and liver function tests are necessary to determine the efficacy of such medication modifications and side effects. This is possible through subsequent follow-ups to ensure that Mary is receiving adequate treatment and also to check whether the side effects of the medication pose a danger to her life. They can also assist with side effects of lipid-lowering therapy and evaluate the achievement of lipid goals. It is necessary to carry out a test for the lipid profile and liver enzymes from time to time, especially for those patients taking lipid-lowering drugs. Therefore, tests for lipid profile and liver function should be done when administering hypercholesterolemia to Mary.

National Guidelines for Hypercholesterolemia Management

Ensuring adequate implementation of national guidelines is an evidence-based management of hypercholesterolemia in elderly patients. Managing hypercholesterolemia in patients with high cardiovascular risk has been elucidated by including detailed guidelines from the ACC/AHA. Carey et al. (2021) acknowledge that such recommendations help clinicians make the proper decisions of starting and adjusting statin therapy for optimal lipid regulation. Hence, applying the ACC/AHA guidelines helps provide Mary with a standard and practical approach to the treatment of her hypercholesterolemia.

Barriers Affecting the Quality of Life of Mary Suffering from Vascular Dementia

Vascular dementia has specific symptoms that may impact Mary in some ways and alter her everyday life. To provide solutions, one must understand the barriers and implement measures to potentially decrease such effects and improve Mary’s quality of life. Uwagbai and Kalish (2020) also mentioned that several difficulties, like cognitive impairment, dependence, and high caregiver burden, are regarded as primary in vascular dementia. All these barriers should be addressed concurrently to optimize Mary’s quality of life. Hence, knowledge of such obstacles could help manage Mary's condition better and improve the experience of both the patient and the caregiver.

Identified Barriers

Cognitive Decline

In the case of Mary, cognitive impairment and progressive memory loss make it difficult for her to remember whether she has taken her medication or not, and many other tasks each day. Memory-related problems are one of the most significant determining factors of the level of functioning that Mary could demonstrate and her ability to remember to take her medications. This can lead to lower doses taken and overall poor health for her as a patient with multiple chronic diseases. According to Uwagbai & Kalish (2020), patients with this type of dementia demonstrate memory and executive impairment, which affects their functioning. Thus, cognitive decline remains critical in planning for Mary and other aspects of her life and well-being.

Reduced Independence

The level of independence and self-sufficiency reduces as the patient requires assistance in specific tasks, proving very harmful to Mary's mental condition. A challenge that directly impacts elderly patients with vascular dementia is the failure to be independent. This may lead to helplessness and even depression if most of the daily activities continue to require the care of the caregivers. According to Quattrocchi et al. (2020), they explain that loss of independence is associated with adverse psychological outcomes among dementia patients. Therefore, autonomy can positively impact Mary's overall well-being and mental health.

Caregiver Burden

Sara, Mary's primary caregiver, becomes more stressed and burdened and ends up with compromised health and capacity to care. A significant concern for patients who require caregivers is known as caregiver burden, which has consequences for the caregiver’s and the patient’s well-being. Working stress and additional responsibilities result in lower quality of care and even caregiver burnout. Zhu & March (2022) state that the caregiver burden is prevalent in families experiencing dementia, which in turn results in the poor health status of the caregiver. As a result, managing the caregiver burden becomes critical to offer Mary prolonged and quality care.

Resources for Mary and Her Daughter

The availability of proper resources can significantly help Mary and her daughter cope with vascular dementia as well as its complications. This is because several healthcare and community services extend support, education, and temporary care to improve their well-being. Quattrocchi et al. (2020) also emphasize the need to combine social support with healthcare, particularly in dementia patients and their caregivers. Using these resources may lessen some of the pressures on Mary and Sara. Hence, integrating Mary and Sara with these resources is crucial for their care as well as the successful treatment of vascular dementia.

Resources

Memory Care Clinics

Outpatient clinics or hospitals may provide various services, such as initial neuropsychological evaluation, treatment strategy development, and caregivers' instruction. Memory care clinics offer specific services to patients with dementia and members of their families. These clinics provide an overview of the head injury and the treatment plan for the cognitive and functional abilities of the affected person. Carey et al. (2021) also emphasized that memory care clinics enhance the care continuum and efficacy in managing dementia. Therefore, memory care clinics can be beneficial in handling Mary’s dementia.

Home Health Services

Such services include assistance in daily activities, medicine administration, and medical services that enable her to remain at home. The services delivered at home help patients gain independence and make it easier for them to access care. Home care can assist with administering drugs, mobility, and monitoring by a healthcare practitioner. According to Hill & Bordoni (2023), home health services benefit patients by enhancing their health and decreasing hospitalization rates. Therefore, planning home health services for Mary can improve her quality of life and health.

Caregiver Support Groups

Such groups provide an opportunity for caregivers to get together and talk about their experiences, as well as seek support and information regarding dementia. Self-help organizations for caregivers offer significant social and informational support to caregivers of dementia patients. These groups support caregivers emotionally by allowing them to share their concerns and ask questions regarding caring for individuals with dementia. According to Uwagbai & Kalish (2020), caregiver support groups positively affect the stress level of the caregivers as well as enhance their coping skills. Thus, it may be beneficial to persuade Sara to attend a caregiver support group that would give her the support and knowledge she requires.

Social Determinant of Health: Access to Healthcare

Mary and Sara’s healthcare needs are critical social determinants that determine the utility of the provided resources, since they should be able to access quality healthcare services. Healthcare can be viewed as an essential social factor influencing the effective prevention and control of chronic diseases such as vascular dementia. Evidence shows that eliminating barriers to accessing healthcare can help patients and their caregivers promptly get the necessary care. According to Zhu & March (2022), enhancing access to healthcare services benefits patients with chronic illnesses, as they can receive better care and improve their overall quality of life. Therefore, measures should be taken to overcome obstacles to Mary and Sara's healthcare access.

Conclusion

Optimizing regimens for hypercholesterolemia drugs according to national guidelines is beneficial in the management of Mary’s condition and her cardiovascular risk. Understanding the barriers that may be associated with vascular dementia and offering the correct information and assistance will go a long way in enhancing Mary's quality of life and addressing the needs of the caregiver. To produce the best outcomes from these interventions, it is critical to guarantee access to healthcare services. Healthcare workers can enhance the treatment of such patients as Mary with multi-morbidity by embracing a systems approach, which is primarily patient-centered. Prescribe atorvastatin 20 mg each day and ezetimibe 10 mg daily while assessing lipid profile and liver enzymes periodically. Management should follow the Recommended ACC/AHA guidelines for risk assessment, statins, and lifestyle changes. Strengthen the aspects of cognitive intervention, encouraging residents' self-sufficiency and decreasing the load on the carers. Consider memory care clinics, home health, and caregiver support groups, primarily focusing on health disparities. By adhering to these recommendations, Mary will receive proper care that addresses her needs and enhances her health status.

Offload drafts to field expert

Our writers can refine your work for better clarity, flow, and higher originality in 3+ hours.

Match with writer

350+ subject experts ready to take on your order

Amanda D.★ 5.0

100% originality guaranteePlagiarism checks with Turnitin